Global Hemoglobinopathies Market By Type (Sickle Cell Disease, Thalassemia, and Others), By Therapy (Monoclonal Antibody Medication, Hydroxyurea, ACE inhibitors, and Others), By Distribution Channel (Hospital Pharmacy, Drug Stores, Online Providers, and Retail Pharmacy), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Sep 2024
- Report ID: 129134
- Number of Pages: 366
- Format:
-
-
-
- Vertex Therapeutics
- Sangamo Therapeutics, Inc.
- Pfizer, Inc.
- Novartis AG Company Profile
- Mindray
- Gamida Cell
- Emmaus Life Sciences Inc.
- Bluebird Bio, Inc.
- Bioverativ Inc.
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |